yes and recent comments comming out of us officialdome point to...

yes and recent comments comming out of us officialdome point to conceding that tamiflu and permiravir have limited lives --- now what does that leave -- it leaves the whole field to rlenza and lani - possibly by the end of nth hemisphere flu season. This probably is the logic and justification for gsk ramping production up further- you can gaurantee most restocking of stockpiles wont be with tamiflu. What a time in the history of anti virals to be negotiating a license deal for lani - my guess is that those large pharmas are on there knees - and that this could be a lot bigger deal for biota than many think - but not all on this site thats for sure. If you are talking about dissapointment - then i'll tell you - i'll be dissapointed with anything less than $10- $20/PER SHARE WITHIN TWELVE MTHS.Dont forget that once you get to $10 - you only have to double to get to twenty.good news is contagious.